Ginger Exosome-Like Nanoparticles for Targeted Periodontitis Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapeutic strategies lack a delivery vehicle that can selectively target multiple virulence factors of pathogens without causing significant toxicity, particularly for chronic infectious diseases like chronic periodontitis caused by Porphyromonas gingivalis, which contributes to conditions such as cardiovascular disease and adverse pregnancy outcomes.
Innovation Solution
Utilizing ginger-derived exosome-like nanoparticles (GELNs) that are selectively taken up by P. gingivalis, targeting multiple virulence factors by delivering biologically active components like miRNAs and lipids, specifically miR-159a-3p and phosphatidic acid (PA), to inhibit bacterial growth, pathogenicity, and bone erosion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If multiple therapeutic agents are delivered to target multiple virulence factors simultaneously, then the effectiveness against microbial infections is improved, but the device complexity and toxicity increase
Solution Approach 1:
The exosome-like nanoparticle (ELN) is designed as a universal delivery vehicle that can carry multiple different therapeutic agents (proteins, RNA, DNA, small molecules) simultaneously. The ELN structure provides multiple binding sites and compartments that can accommodate diverse payloads, enabling one delivery system to perform multiple therapeutic functions against different virulence factors of the same or different pathogens.
Solution Approach 2:
The ELN acts as an intermediary carrier between the therapeutic agents and the pathogenic bacteria. Instead of directly administering multiple complex therapeutic agents, they are first loaded into the ELN structure which then delivers them to the target bacteria. The ELN mediates the interaction by protecting the payloads during delivery and facilitating their release at the target site, thereby simplifying the overall therapeutic approach.
2Measurement precision
If selective targeting of pathogens is achieved, then the precision of treatment is improved, but the manufacturing precision and complexity increase
Solution Approach 1:
The ELN achieves selective targeting through local quality differentiation on its surface. Specific surface proteins, lipids, or other molecules are localized at particular regions of the nanoparticle surface, creating targeted recognition sites that bind specifically to receptors on pathogenic bacteria. This localized functionalization allows the ELN to distinguish between different bacterial types and selectively target only the desired pathogens while leaving other bacteria unaffected.
3Reliability
If therapeutic agents are delivered to inhibit bacterial pathogenicity, then the treatment effectiveness is improved, but the harmful factors and side effects increase
Solution Approach 1:
The ELN converts potentially harmful components into beneficial therapeutic agents. For example, certain bacteria produce virulence factors that are harmful to the host, but the ELN can be designed to carry anti-virulence proteins or RNAs that neutralize these harmful factors. By delivering these counteracting agents specifically to the pathogen, the ELN transforms the battle against harmful bacterial factors into a targeted therapeutic action with minimal harm to the host.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
GELNs effectively reduce P. gingivalis growth, attachment, and pathogenicity, thereby preventing periodontitis and alveolar bone loss, with minimal side effects, and modulating the gut microbiome to protect against alcohol-induced liver damage.
Implementation Method 1
GELNs are selectively taken up by P. gingivalis, and upon being taken up, the pathogenicity of P. gingivalis is significantly reduced
Data Source
AI summary
Provided are methods for preventing and/or treating oral diseases, disorders, and/or conditions. In some embodiments, the methods relate to administering to the oral cavity of a subject in need thereof a composition that includes an effective amount of ginger-derived exosome-like nanoparticles (GELNs) or a biologically active component thereof. Also provided are methods for preventing and/or treating periodontitis, methods for reducing growth of and/or pathogenicity of microorganisms in the oral cavities of subjects, methods for reducing microorganismal motility, and methods for reducing bone loss in the oral cavities of subjects associated with infection with microorganisms. Also provided are compositions that can be employed in the disclosed methods.